Vanta Bioscience shines on inking CRO agreement with Emcure Pharmaceuticals

08 Apr 2019 Evaluate

Vanta Bioscience is currently trading at Rs. 194.00, up by 9.00 points or 4.86% from its previous closing of Rs. 185.00 on the BSE.

The scrip opened at Rs. 186.00 and has touched a high and low of Rs. 194.00 and Rs. 183.00 respectively. So far 7500 shares were traded on the counter.

The BSE group 'M' stock of face value Rs. 10 has touched a 52 week high of Rs. 194.00 on 08-Apr-2019 and a 52 week low of Rs. 46.00 on 07-Jun-2018.

Last one week high and low of the scrip stood at Rs. 194.00 and Rs. 142.00 respectively. The current market cap of the company is Rs. 122.45 crore.

The promoters holding in the company stood at 72.45%, while Non-Institutions held 27.55% stake in the company.

Vanta Bioscience through its step down subsidiary -- Vayam Research Solutions has entered into a non-exclusive CRO Service Agreement with Emcure Pharmaceuticals, Pune, for providing services of Bio-Analytical and Bio-Equivalence services to the said company for a period of three years from 2019 to 2022.

The CRO Service Agreement provides for a minimum revenue assurance between Rs 7 crore to Rs 9 crore for the financial year 2019-2020 and Rs 20 crore for financial year 2020-2021.

Vanta Bioscience is a preclinical contract research organization, offering a host of preclinical safety assessment services for clientele from Pharmaceutical, Medical Devices, Nutraceuticals, Feed Additive, Biotech, Agrochemicals, Cosmetics, and Chemical industries.

Vanta Bioscience Share Price

73.50 0.00 (0.00%)
16-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Syngene Internation. 690.00
EKI Energy Services 329.85
AGS Transact Tech 76.36
Just Dial 999.60
Krystal Integrated 705.10
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.